Dr. Muhammad Junaid, Dr. Muhammad Ahsan, Dr. Ameer Hamza
Introduction: According to estimates from the International Agency for Research on Cancer (IARC), there were 14.1 million new cancer cases in 2012 worldwide, of which 8 million occurred in economically developing countries, which contain about 82% of the world’s population. Objectives of the study: This study was designed to evaluate the status of macronutrients such as Ca and Fe and micronutrients such as Cu, Zn and Se in brain tumor patients. Methodology of the study: This descriptive study was conducted in Jinnah Hospital Lahore during January 2019 to July 2019. The patient who were come at hospital for treatment, selected for this study. Results: The analysis of blood micro and macro nutrients shows that there is a huge difference in control group and patients. Conclusion: It is concluded that quality of life is very much important in brain tumor therapies. The level of nutrients become decreases due to tumor that’s why it is necessary to maintain the normal values of nutrients. So that patient may survive better quality life.